ストックスクリーナーアプリを入手
1.37
4.58%
0.06
アフターアワーズ：
1.37
前日終値:
$1.31
開ける：
$1.32
24時間の取引高:
205.99K
Relative Volume:
0.07
時価総額：
$44.22M
収益：
-
当期純損益:
$-16.14M
株価収益率:
-2.537
EPS:
-0.54
ネットキャッシュフロー:
$-3.99M
1週間 パフォーマンス:
-8.67%
1か月 パフォーマンス:
-16.97%
6か月 パフォーマンス:
-44.98%
1年 パフォーマンス:
-67.54%
1日の値動き範囲:
$1.32
$1.395
1週間の範囲:
$1.2723
$1.505
52週間の値動き範囲:
$1.12
$7.0791
Telomir Pharmaceuticals Inc Stock (TELO) Company Profile
TELO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TELO
Telomir Pharmaceuticals Inc
|
1.37 | 44.32M | 0 | -16.14M | -3.99M | -0.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.20 | 103.89B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
654.74 | 69.11B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.70 | 58.49B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
869.83 | 52.62B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
191.92 | 40.46B | 447.02M | -1.18B | -906.14M | -6.1812 |
Telomir Pharmaceuticals Inc Stock (TELO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-21 | 開始されました | Rodman & Renshaw | Buy |
Telomir Pharmaceuticals Inc (TELO) 最新ニュース
Telomir Pharmaceuticals Inc. (TELO) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Will Telomir Pharmaceuticals Inc. bounce back from current support2025 AllTime Highs & Verified Short-Term Plans - newser.com
Has Telomir Pharmaceuticals Inc. found a price floor2025 Trading Volume Trends & Weekly Top Gainers Alerts - newser.com
How Telomir Pharmaceuticals Inc. stock reacts to global recession fears2025 Market Outlook & Safe Entry Momentum Stock Tips - newser.com
What technical models suggest about Telomir Pharmaceuticals Inc.’s comebackCEO Change & Free High Return Stock Watch Alerts - newser.com
Analyzing Telomir Pharmaceuticals Inc. with risk reward ratio charts2025 AllTime Highs & Technical Confirmation Alerts - newser.com
Forecasting Telomir Pharmaceuticals Inc. price range with options dataWeekly Trade Report & Fast Gaining Stock Reports - newser.com
Sentiment analysis tools applied to Telomir Pharmaceuticals Inc.CEO Change & Weekly Market Pulse Updates - newser.com
Will Telomir Pharmaceuticals Inc. rebound enough to break evenWeekly Profit Analysis & Long-Term Safe Investment Plans - newser.com
Telomir Pharmaceuticals Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
What’s the recovery path for long term holders of Telomir Pharmaceuticals Inc.Earnings Risk Report & Advanced Technical Signal Analysis - newser.com
Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells - The Daily News Journal
What insider trading reveals about Telomir Pharmaceuticals Inc. stockPortfolio Risk Report & Weekly High Potential Alerts - newser.com
Momentum divergence signals in Telomir Pharmaceuticals Inc. chart2025 Bull vs Bear & Stock Market Timing Techniques - newser.com
Telomir Pharmaceuticals, Inc. (TELO) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Does Telomir Pharmaceuticals Inc. show high probability of reboundJuly 2025 Closing Moves & Low Risk Investment Opportunities - newser.com
Short Interest in Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) Increases By 43.5% - MarketBeat
Telomir Pharmaceuticals Inc. stock chart pattern explainedTrade Risk Assessment & Free Daily Entry Point Trade Alerts - newser.com
Market reaction to Telomir Pharmaceuticals Inc.’s recent newsJuly 2025 Action & High Accuracy Swing Entry Alerts - newser.com
Telomir Pharmaceuticals announces new laboratory findings on Telomir-1 - MSN
Why Telomir Pharmaceuticals Inc. stock attracts global investorsJuly 2025 Trends & Community Consensus Picks - newser.com
Telomir Pharmaceuticals Inc (TELO) 財務データ
収益
当期純利益
現金流量
EPS
0.05%
1.40%
大文字化:
|
ボリューム (24 時間):